All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Abstract

Angiotensin Receptor Antagonists A New Class Of Antihypertensive Drugs

Author(s): Zeenat S Hakim, Milan C Satia, Ramesh K Goyal

Losartan is an orally active, non-peptide Angiotensin II (AT1specific) antagonist. It is a new and promising antihypertesive agent, better than ACE inhibitors in controlling hypertesion. Its antihypertensive effect is enhanced when given in combination with hydrochlorthiazide (HCT) or an ACE inhibitor. Among other angiotensin receptor antagonists are TCV- 116, CV-11974, and CV-11194, all of which seem to be promising antihypertensives of the future. Results of the studies on losartan and other angiotensin receptor antagonists indicate that they would certainly acquire a commanding position in the treatment of hypertension, a disease that makes millions of people suffer.